Combined Immunotherapy with Intracavital Injection of Activated Lymphocytes, Monocyte-derived Dendritic Cells and Low-dose OK-432 in Patients with Malignant Effusion

Takashi Morisaki, Kotaro Matsumoto, Hideo Kuroki, Makoto Kubo, Eishi Baba, Hideya Onishi, Akira Tasaki, Mitsunari Nakamura, Syoichi Inaba, Mitsuo Katano

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

We have conducted a pilot study with combined immunotherapy using autologous lymphocytes activated ex vivo and monocyte-derived dendritic cells in combination with low-dose OK-432, a streptococcal preparation, in five patients with peritoneal or pleural carcinornatosis who were resistant to standard chemotherapy. All patients were given 3 to 10 courses of the combined immunotherapy. No severe adverse reactions occurred. Effusion production was decreased in all of the patients. Significant decreases in tumor markers of both effusions and sera as well as effusion volume occurred in all of the patients. Cytological examinations revealed a marked decrease or disappearance of cancer cells in those effusions. Three patients showed increase in IFN-γ levels in the effusions. The overall prognosis of the patients was acceptable and the mean survival time was more than 9 months. The locoregional immunotherapy seems to be encouraging in view of therapeutic modality in patients who are resistant to standard chemotherapy. Our study provides a new protocol for immunotherapy and warrants further phase I/II clinical study for chemo-resistant patients with malignant effusion.

Original languageEnglish
Pages (from-to)4459-4465
Number of pages7
JournalAnticancer research
Volume23
Issue number6 A
Publication statusPublished - Nov 1 2003

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Combined Immunotherapy with Intracavital Injection of Activated Lymphocytes, Monocyte-derived Dendritic Cells and Low-dose OK-432 in Patients with Malignant Effusion'. Together they form a unique fingerprint.

  • Cite this